Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.

Collet J-P., Thiele H., Barbato E., Barthélémy O., Bauersachs J., Bhatt DL., Dendale P., Dorobantu M., Edvardsen T., Folliguet T., Gale CP., Gilard M., Jobs A., Jüni P., Lambrinou E., Lewis BS., Mehilli J., Meliga E., Merkely B., Mueller C., Roffi M., Rutten FH., Sibbing D., Siontis GCM., ESC Scientific Document Group .

More information Original publication

DOI

10.1093/eurheartj/ehaa575

Type

Journal article

Publication Date

2021-04-07T00:00:00+00:00

Volume

42

Pages

1289 - 1367

Total pages

78

Keywords

European Society of Cardiology, Guidelines, acute cardiac care, acute coronary syndrome, angioplasty, anticoagulation, antiplatelet, apixaban, aspirin, atherothrombosis, betablockers, bivalirudin, bleedings, bypass surgery, cangrelor, chest pain unit, clopidogrel, dabigatran, diabetes, dual antithrombotic therapy, early invasive strategy, edoxaban, enoxaparin, fondaparinux, glycoprotein IIb/IIIa inhibitors, heparin, high-sensitivity troponin, minoca, myocardial infarction, myocardial ischaemia, nitrates, non-ST-elevation myocardial infarction, platelet inhibition, prasugrel, recommendations, revascularization, rhythm monitoring, rivaroxaban, stent, ticagrelor, triple therapy, unstable angina, Acute Coronary Syndrome, Disease Management, Humans